Compare $CTMX vs $PBYI | Chartloom

Compare

$CTMX vs $PBYI

CytomX Therapeutics Inc · Puma Biotechnology Inc

CTMX

CytomX Therapeutics Inc

PBYI

Puma Biotechnology Inc

Compare $CTMX vs $PBYI

Comparing CytomX Therapeutics Inc and Puma Biotechnology Inc

CTMXCytomX Therapeutics Inc

PBYIPuma Biotechnology Inc

CTMXCytomX Therapeutics Inc

Market cap

$559M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

32.52x

Rev growth (TTM)

-87.0%

YTD performance

-39.5%

52W performance

-23.7%

FCF yield

-14.8%

PBYIPuma Biotechnology Inc

Market cap

$524M

P/E (TTM)

20.26x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-2.9%

YTD performance

78.3%

52W performance

96.7%

FCF yield

7.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTMX

PBYI

Detailed metrics comparison

CTMX

CytomX Therapeutics Inc

PBYI

Puma Biotechnology Inc

Market Cap

CTMX$559M

PBYI$524M

Enterprise Value

CTMX$542M

PBYI$487M

Price

CTMX$2.57

PBYI$10.29

P/E Ratio

CTMXN/A

PBYI20.26x

P/S Ratio

CTMX30.57x

PBYI2.26x

EV/Sales

CTMX29.63x

PBYI2.11x

EV/EBITDA

CTMX22.17x

PBYI10.51x

P/B Ratio

CTMX1.85x

PBYI3.54x

P/FCF Ratio

CTMXN/A

PBYI12.75x

EV/FCF

CTMX-6.55x

PBYI11.86x

PEG Ratio

CTMXN/A

PBYIN/A

Forward P/E (NTM)

CTMXN/A

PBYIN/A

Forward P/S (NTM)

CTMX32.52x

PBYIN/A

Revenue (TTM)

CTMX$18M

PBYI$231M

Revenue Growth (YoY)

CTMX-87.0%

PBYI-2.9%

Forward Rev Growth

CTMX35.7%

PBYI-1.4%

Gross Margin (TTM)

CTMX0.0%

PBYI74.8%

Operating Margin (TTM)

CTMX0.0%

PBYI13.2%

EBITDA Margin (TTM)

CTMX-471.6%

PBYI17.7%

Net Margin (TTM)

CTMX-451.6%

PBYI11.6%

FCF Margin (TTM)

CTMX-452.1%

PBYI17.8%

Net Income (TTM)

CTMX$-83M

PBYI$27M

FCF (TTM)

CTMX$-83M

PBYI$41M

EPS (TTM)

CTMX-$0.38

PBYI$0.51

ROE (TTM)

CTMX-3846.0%

PBYI20.8%

ROA (TTM)

CTMX-3033.0%

PBYI13.3%

ROIC (TTM)

CTMX-3846.0%

PBYI18.4%

Cash

CTMX$17M

PBYI$37M

Debt

CTMX$0

PBYI$0

Net Cash/Debt

CTMX$17M

PBYI$37M

Current Ratio (TTM)

CTMX9.36x

PBYI2.91x

Quick Ratio (TTM)

CTMX9.25x

PBYI2.57x

Debt/Equity (TTM)

CTMX0.00x

PBYI0.17x

Debt/Assets (TTM)

CTMX0.0%

PBYI0.0%

Interest Coverage (TTM)

CTMXN/A

PBYIN/A

Net Debt/EBITDA (TTM)

CTMX0.00x

PBYI0.00x

Beta

CTMX2.26

PBYI1.36

52W Performance

CTMX-23.7%

PBYI96.7%

YTD Performance

CTMX-39.5%

PBYI78.3%

% from 52W High

CTMX-68.7%

PBYI-0.8%

% from 52W Low

CTMX5.8%

PBYI124.7%

Asset Turnover (TTM)

CTMX0.07x

PBYI1.15x

FCF Yield (TTM)

CTMX-14.8%

PBYI7.8%

Earnings Yield (TTM)

CTMX-14.8%

PBYI5.1%

Dividend Yield (TTM)

CTMXN/A

PBYIN/A

Rule of 40

CTMX-539.1

PBYI14.9

EV/GP/RG

CTMXN/A

PBYIN/A

Ticker research

View CTMX research View PBYI research

Metric	CTMX CytomX Therapeutics Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$559M	$524M
Enterprise Value	$542M	$487M
Price	$2.57	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	30.57x	2.26x
EV/Sales	29.63x	2.11x
EV/EBITDA	22.17x	10.51x
P/B Ratio	1.85x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-6.55x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	32.52x	N/A
Revenue & Growth
Revenue (TTM)	$18M	$231M
Revenue Growth (YoY)	-87.0%	-2.9%
Forward Rev Growth	35.7%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	-471.6%	17.7%
Net Margin (TTM)	-451.6%	11.6%
FCF Margin (TTM)	-452.1%	17.8%
Net Income (TTM)	$-83M	$27M
FCF (TTM)	$-83M	$41M
EPS (TTM)	-$0.38	$0.51
ROE (TTM)	-3846.0%	20.8%
ROA (TTM)	-3033.0%	13.3%
ROIC (TTM)	-3846.0%	18.4%
Financial Health
Cash	$17M	$37M
Debt	$0	$0
Net Cash/Debt	$17M	$37M
Current Ratio (TTM)	9.36x	2.91x
Quick Ratio (TTM)	9.25x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	1.36
52W Performance	-23.7%	96.7%
YTD Performance	-39.5%	78.3%
% from 52W High	-68.7%	-0.8%
% from 52W Low	5.8%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	1.15x
FCF Yield (TTM)	-14.8%	7.8%
Earnings Yield (TTM)	-14.8%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-539.1	14.9
EV/GP/RG	N/A	N/A
Ticker research	View CTMX research	View PBYI research

Valuation

P/E Ratio

PBYI

20.26x

P/S Ratio

PBYI

2.26x

CTMX

30.57x

EV/FCF

CTMX

-6.55x

PBYI

11.86x

Growth & revenue

Revenue Growth TTM

PBYI

-2.9%

CTMX

-87.0%

Forward Revenue Growth

CTMX

35.7%

PBYI

-1.4%

Profitability & performance

Gross Margin

PBYI

74.8%

CTMX

0.0%

ROE

PBYI

20.8%

CTMX

-3846.0%

FCF Yield %

PBYI

7.8%

CTMX

-14.8%

52-Week Performance

PBYI

96.7%

CTMX

-23.7%

Detailed metrics comparison

CTMX

CytomX Therapeutics Inc

PBYI

Puma Biotechnology Inc

Market Cap

CTMX$559M

PBYI$524M

Enterprise Value

CTMX$542M

PBYI$487M

Price

CTMX$2.57

PBYI$10.29

P/E Ratio

CTMXN/A

PBYI20.26x

P/S Ratio

CTMX30.57x

PBYI2.26x

EV/Sales

CTMX29.63x

PBYI2.11x

EV/EBITDA

CTMX22.17x

PBYI10.51x

P/B Ratio

CTMX1.85x

PBYI3.54x

P/FCF Ratio

CTMXN/A

PBYI12.75x

EV/FCF

CTMX-6.55x

PBYI11.86x

PEG Ratio

CTMXN/A

PBYIN/A

Forward P/E (NTM)

CTMXN/A

PBYIN/A

Forward P/S (NTM)

CTMX32.52x

PBYIN/A

Revenue (TTM)

CTMX$18M

PBYI$231M

Revenue Growth (YoY)

CTMX-87.0%

PBYI-2.9%

Forward Rev Growth

CTMX35.7%

PBYI-1.4%

Gross Margin (TTM)

CTMX0.0%

PBYI74.8%

Operating Margin (TTM)

CTMX0.0%

PBYI13.2%

EBITDA Margin (TTM)

CTMX-471.6%

PBYI17.7%

Net Margin (TTM)

CTMX-451.6%

PBYI11.6%

FCF Margin (TTM)

CTMX-452.1%

PBYI17.8%

Net Income (TTM)

CTMX$-83M

PBYI$27M

FCF (TTM)

CTMX$-83M

PBYI$41M

EPS (TTM)

CTMX-$0.38

PBYI$0.51

ROE (TTM)

CTMX-3846.0%

PBYI20.8%

ROA (TTM)

CTMX-3033.0%

PBYI13.3%

ROIC (TTM)

CTMX-3846.0%

PBYI18.4%

Cash

CTMX$17M

PBYI$37M

Debt

CTMX$0

PBYI$0

Net Cash/Debt

CTMX$17M

PBYI$37M

Current Ratio (TTM)

CTMX9.36x

PBYI2.91x

Quick Ratio (TTM)

CTMX9.25x

PBYI2.57x

Debt/Equity (TTM)

CTMX0.00x

PBYI0.17x

Debt/Assets (TTM)

CTMX0.0%

PBYI0.0%

Interest Coverage (TTM)

CTMXN/A

PBYIN/A

Net Debt/EBITDA (TTM)

CTMX0.00x

PBYI0.00x

Beta

CTMX2.26

PBYI1.36

52W Performance

CTMX-23.7%

PBYI96.7%

YTD Performance

CTMX-39.5%

PBYI78.3%

% from 52W High

CTMX-68.7%

PBYI-0.8%

% from 52W Low

CTMX5.8%

PBYI124.7%

Asset Turnover (TTM)

CTMX0.07x

PBYI1.15x

FCF Yield (TTM)

CTMX-14.8%

PBYI7.8%

Earnings Yield (TTM)

CTMX-14.8%

PBYI5.1%

Dividend Yield (TTM)

CTMXN/A

PBYIN/A

Rule of 40

CTMX-539.1

PBYI14.9

EV/GP/RG

CTMXN/A

PBYIN/A

Ticker research

View CTMX research View PBYI research

Metric	CTMX CytomX Therapeutics Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$559M	$524M
Enterprise Value	$542M	$487M
Price	$2.57	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	30.57x	2.26x
EV/Sales	29.63x	2.11x
EV/EBITDA	22.17x	10.51x
P/B Ratio	1.85x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-6.55x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	32.52x	N/A
Revenue & Growth
Revenue (TTM)	$18M	$231M
Revenue Growth (YoY)	-87.0%	-2.9%
Forward Rev Growth	35.7%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	-471.6%	17.7%
Net Margin (TTM)	-451.6%	11.6%
FCF Margin (TTM)	-452.1%	17.8%
Net Income (TTM)	$-83M	$27M
FCF (TTM)	$-83M	$41M
EPS (TTM)	-$0.38	$0.51
ROE (TTM)	-3846.0%	20.8%
ROA (TTM)	-3033.0%	13.3%
ROIC (TTM)	-3846.0%	18.4%
Financial Health
Cash	$17M	$37M
Debt	$0	$0
Net Cash/Debt	$17M	$37M
Current Ratio (TTM)	9.36x	2.91x
Quick Ratio (TTM)	9.25x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	1.36
52W Performance	-23.7%	96.7%
YTD Performance	-39.5%	78.3%
% from 52W High	-68.7%	-0.8%
% from 52W Low	5.8%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	1.15x
FCF Yield (TTM)	-14.8%	7.8%
Earnings Yield (TTM)	-14.8%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-539.1	14.9
EV/GP/RG	N/A	N/A
Ticker research	View CTMX research	View PBYI research